ELECTROMAGNETIC STIMULATION FOR ALLEVIATING CHRONIC PELVIC PAIN IN WOMEN

Abstract Objectives Chronic pelvic pain (CPP), often associated with increased hypertonicity or overactivity of the pelvic floor muscles, affects 6% to 16% of women worldwide. It is characterized by persistent, non-specific pain without a clear clinical cause. This study aimed to assess the efficacy and safety of a new device that utilizes Top Flat Magnetic Stimulation (TFMS) to manage pelvic muscle hypertonia in women with CPP, using validated questionnaires to measure outcomes. Methods Twenty participants underwent eight treatment sessions with a non-invasive electromagnetic therapeutic device. The device generates uniform TFMS, which targets muscle activity to alleviate pain and inhibit hypertonic muscle responses. The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) was employed to evaluate improvements, and any side effects were carefully monitored throughout the study. Results The total mean PISQ-12 score decreased significantly from 29.2 (± 3.3) to 17 (± 2). Behavioral-emotional item scores (questions 1-4) showed a reduction from 12 (± 2) to 7 (± 0.9), indicating an improvement in the emotional and psychological impact of CPP. Physical item scores (questions 5-9) decreased from 10.6 (± 1.8) to 6 (± 1.4), suggesting relief in physical discomfort. The Partner-Related item scores (questions 10-12) also improved, dropping from 6.6 (± 1.6) to 3.9 (± 0.4), indicating enhanced relationship dynamics. Conclusions The device used in this study demonstrated a significant reduction in pain and muscle hyperactivity, showing promise as a safe and effective treatment option for chronic pelvic pain in women. The consistent improvement across all domains of the PISQ-12 underscores the potential of TFMS for managing CPP, offering both physical relief and improved emotional and relationship well-being for patients. Conflicts of Interest none.